Combined transcarotid transcatheter aortic valve implantation and endarterectomy of the ipsilateral internal carotid artery.

The transcarotid pathway remains a safe route for transcatheter aortic valve implantation (TAVI) when more traditional approaches are contraindicated. We report a series of three patients with severe aortic stenosis (AS) and symptomatic significant stenosis of the ipsilateral internal carotid artery (ICA) in patients with high operative risk. All patients were treated successfully within the same setting in our center by endarterectomy first followed by a TAVI with an uneventful postoperative course without new neurological deficits (Modine et al.

[Carcinoid heart disease].

Carcinoid cardiac disease is a common complication of metastatic carcinoid tumours. It is characterized by tricuspid regurgitation and pulmonary stenosis. A 68 years old woman with a metastatic carcinoid tumour was admitted to hospital for congestive cardiac failure secondary to severe tricuspid regurgitation.

The stentless Bravo 300 aortic porcine xenograft: supra-annular versus annular implantation.

The aim of the study was to compare the supra-annular and intra-annular implantation techniques by evaluating the differences in early haemodynamic outcome (gradients, effective orifice area, regurgitation). Since August 1991, 200 stentless Bravo model 300 valves have been implanted. Patients were divided into three groups of consecutive cases: group 1 (n = 50) represents exclusively intra-annular implantation; group 2 (n = 50) is a transitional period: and group 3 (n = 100) comprises only patients with supra-annular implantation.

[Repair of post-infarction left ventricular wall ruptures by biological glue and a flap from the pericardium. Results from 2 to 10 years].

The authors report their experience with a simple and efficient technique for repair of left ventricular free wall rupture complicating myocardial infarction. The technique consists, with the aid of cardiopulmonary bypass, in suturing a plaque of the patients own pericardium (6 to 8 cm in diameter) to the more normal tissue encircling the pathologic myocardium, and by injecting five ml of human fibrin glue as a cement under the pericardium to reinforce the remair and prevent leaking throughout the suture line. With a 10 year follow-up, we are able to be confident with the long term results.